Form 4: KORU Medical Systems CFO Acquires Shares
Statement of Changes in Beneficial Ownership
KORU Medical Systems' Chief Financial Officer, Thomas Edward Adams, has acquired a significant number of company shares through a Rule 10b5-1(c) plan.
Summary
- Thomas Edward Adams, Chief Financial Officer of KORU Medical Systems, Inc., reported the acquisition of 5,041 shares of common stock on May 14, 2026, at a price of $3.86 per share.
- Additionally, Mr. Adams acquired 459 shares of common stock on the same date at a price of $3.90 per share.
- Following these transactions, Mr. Adams beneficially owns a total of 308,147 shares of common stock directly.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents an insider purchase under a pre-planned strategy, indicating confidence without providing new financial information.
Positives
- The Chief Financial Officer's acquisition of company stock, executed under a pre-arranged trading plan (Rule 10b5-1(c)), can be interpreted as a positive signal of confidence in the company's future prospects.
- The transactions indicate a direct investment by a key executive in the company's equity.
Future Outlook
The filing itself does not contain forward-looking statements or guidance. The transactions reported are historical acquisitions.
Industry Context
StockSavvy.ai notes that insider stock purchases, particularly by CFOs and under Rule 10b5-1(c) plans, are often viewed by the market as indicators of management's belief in the company's valuation and future performance. This type of filing is standard for reporting such transactions.
Stakeholder Impact
- Shareholders may view the CFO's stock purchase as a positive signal of confidence in the company's future performance.
- Employees may interpret this as a sign of stability and executive commitment.
- Creditors and suppliers are unlikely to be directly impacted by this filing.
Key Dates
| Date | Description |
|---|---|
| 05/14/2026 | Date of earliest transaction reported (acquisition of common stock). |
| 05/18/2026 | Date of signature on the filing. |
Keywords
KORU Medical Systems, KRMD, Form 4, Insider Trading, Stock Acquisition, Beneficial Ownership, Thomas Edward Adams, Chief Financial Officer, Rule 10b5-1(c)
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.